A Randomized, Double-blind, Parallel-group, 26-week Study Comparing the Efficacy and Safety of Indacaterol (Onbrez® Breezhaler® 150 mcg o.d.) With Salmeterol/Fluticasone Propionate (Seretide® Accuhaler® 50 mcg/500 mcg b.i.d.) in Patients With Moderate Chronic Obstructive Pulmonary Disease
A Randomized, Double-blind, Parallel-group, 26-week Study Comparing the Efficacy and Safety of Indacaterol (Onbrez® Breezhaler® 150 mcg o.d.) With Salmeterol/Fluticasone Propionate (Seretide® Accuhaler® 50 mcg/500 mcg b.i.d.) in Patients With Moderate Chronic Obstructive Pulmonary Disease
The purpose of this study is to compare the effectiveness and safety of indacaterol with salmeterol /fluticasone propionate treatment in patients with moderate chronic obstructive pulmonary disease who, on entry to the study are being treated with salmeterol /fluticasone propionate.
Inclusion Criteria:
Exclusion Criteria:
Other protocol-defined inclusion/exclusion criteria may apply.
Caba, Argentina C1119ACN, Argentina
Buenos Aires, Buenos Aires 1425, Argentina
Buenos Aires, Buenos Aires B6500EZL, Argentina
Buenos Aires, Buenos Aires C1120AAC, Argentina
Buenos Aires, Buenos Aires C1125ABE, Argentina
C A B A, Buenos Aires, Argentina
Caba, Buenos Aires 1028, Argentina
Caba, Buenos Aires 1122, Argentina
Caba, Buenos Aires 1209, Argentina
Caba, Buenos Aires 1425, Argentina
Caba, Buenos Aires B8000XAV, Argentina
Caba, Buenos Aires C1056ABJ, Argentina
Caba, Buenos Aires C1122AAK, Argentina
Caba, Buenos Aires C1280AEB, Argentina
Caba, Buenos Aires C1414AIF, Argentina
Caba, Buenos Aires C1425DQI, Argentina
Bogota, Cundinamarca, Colombia
Wilayah Persekutuan, Kuala Lumpur 50590, Malaysia
Muenchenstein, Switzerland 4241, Switzerland
Hants, Southampton SO9 5NY, United Kingdom
East Yorkshire, HU16 5JQ, United Kingdom
Surrey, KT16 0PZ, United Kingdom